Dr. Sklavenitis Pistofidis speaks at #ASH25 about genomic & immune biomarkers of progression to MM

Written By RSP

Dr. Sklavenitis Pistofidis spoke at a scientific workshop on Exploring the Origins of Multiple Myeloma at the 67th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida. His talk focused on genomic & immune biomarkers of progression from MGUS and SMM to overt MM.

Watch an interview with Matrix Medical Communications here and here, and read more about the workshop here.

Read the coverage by ASH News Daily here.

RSP
Previous

SWIFT-seq on STAT News!
Next

Dr. Sklavenitis Pistofidis speaks to Blood Cancers Today about SWIFT-seq